NASDAQ · Financial Statements
ESSA Pharma Inc. (EPIX) Financial Statements
$0.20
NASDAQ: EPIX
Market Cap $9.52M
Overview Financials Dividend ESSA Pharma Inc. most recently reported annual revenue of $0, net profit of $-29.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $0 $0 $0 $0 Operating Profit $-23.0M $-37.0M $-35.0M $-32.0M $-34.0M Net Profit $-23.0M $-37.0M $-35.0M $-27.0M $-29.0M EPS $-1.04 $-0.96 $-0.80 $-0.60 $-0.64 Op Margin — — — — —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $81.0M $198.0M $170.0M $149.0M $128.0M Total Liabilities $1.0M $4.0M $2.0M $3.0M $4.0M Cash $56.0M $138.0M $57.0M $34.0M $104.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-17.0M $-25.0M $-29.0M $-20.0M $-23.0M Investing Cash Flow $-22.0M $-35.0M $-52.0M $-4.0M $92.0M Financing Cash Flow $-3.0M $-8.0M $0 $0 $1.0M Net Cash Flow $3.0M $82.0M $-81.0M $-23.0M $70.0M Free Cash Flow $-17.0M $-25.0M $-29.0M $-20.0M $-23.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.11 EV / EBITDA 6.75 FCF Yield -116.08% Quick Ratio 69.07 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock